Compare Avalon Labs (AVL) vs Injective (INJ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Avalon Labs vs Injective — how do they compare? Avalon Labs trades at Rp283.63 (market cap Rp45,69M, Rp18,69M 24h volume), while Injective trades at Rp76,667 (market cap Rp7,62T, Rp1,02T 24h volume). The key difference: Injective is far larger — about 166776.1× Avalon Labs's market cap, and Avalon Labs's supply is capped (161,7M / 1B AVL (17%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Avalon Labs for 9 Days and Injective for 37 Days on average.
| AVL | INJ | |
|---|---|---|
Market Cap | Rp45,69M | Rp7,62T |
Volume (24h) | Rp18,69M | Rp1,02T |
Circulating Supply | 161,7M / 1B AVL (17%) | 100M INJ |
Typical Hold Time | 9 Days | 37 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AVL is trading at Rp286.54 with a bearish technical outlook, showing sell signals across moving averages while oscillators remain neutral. The token faces resistance at Rp288 with support at Rp280, indicating potential downside pressure. With only 17% of max supply circulating and average hold time of 9 days, liquidity remains limited. Recent news shows no direct crypto ecosystem developments for this token.
Overall outlook remains cautious with bearish technical momentum outweighing neutral oscillators. Key opportunity lies in potential breakout above Rp288 resistance, while major risks include low liquidity, limited circulation, and absence of recent protocol updates. Investors should monitor for any blockchain ecosystem developments that could drive adoption.
Injective (INJ) is currently trading at Rp75,554 with a market cap of Rp7.49T, exhibiting a bearish technical signal as indicated by moving averages. The asset trades below its pivot point of Rp82,186, with key support at Rp81,456 and resistance at Rp82,576. Recent on-chain data shows an average hold time of 37 days, suggesting moderate holding behavior.
The overall outlook is cautious due to bearish technical indicators and neutral oscillators. Key opportunities lie in potential rebounds from support levels, while major risks include high volatility and the absence of recent significant protocol updates. Investors should monitor trading volume and broader crypto market trends closely.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Avalon Labs
Avalon Labs is building an on-chain financial center for Bitcoin, offering solutions like BTC-backed lending, a Bitcoin-backed stablecoin, yield-generating accounts, and a credit card. Our goal is to create a scalable, transparent, and accessible financial network for Bitcoin holders to use Bitcoin as an economic asset. AVL is the governance token of the Avalon Labs ecosystem. We started as the world's largest issuer of Bitcoin-backed collateralized debt positions (CDPs) and have since expanded into DeFi lending, fixed-rate CeDeFi models, and stablecoins. This growth, driven by community demand, positions Avalon as a leader in on-chain finance. With AVL, we empower our community to actively shape the future of Avalon.
Read more on AVL →About Injective
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →
